Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Diagnostic workup of childhood interstitial lung disease.
Nathan N, Griese M, Michel K, Carlens J, Gilbert C, Emiralioglu N, Torrent-Vernetta A, Marczak H, Willemse B, Delestrain C, Epaud R; ERS CRC chILD-EU group. Nathan N, et al. Among authors: emiralioglu n. Eur Respir Rev. 2023 Feb 21;32(167):220188. doi: 10.1183/16000617.0188-2022. Print 2023 Mar 31. Eur Respir Rev. 2023. PMID: 36813289 Free PMC article. Review.
Cystic fibrosis in Turkey: First data from the national registry.
Dogru D, Çakır E, Şişmanlar T, Çobanoğlu N, Pekcan S, Cinel G, Yalçın E, Kiper N, Şen V, S Şen H, Ercan Ö, Keskin Ö, B Eltan S, Al Shadfan LM, Yazan H, Altıntaş DU, Şaşihüseyinoğlu Ş, Sapan N, Çekiç Ş, Çokuğraş H, A Kılınç A, R Gürsoy T, Aslan AT, Bingöl A, Başaran AE, Özdemir A, Köse M, Hangül M, Emiralioğlu N, Tuğcu G, Yüksel H, Yılmaz Ö, Orhan F, Gayretli Aydın ZG, Topal E, Tamay Z, Süleyman A, Can D, Bal CM, Çaltepe G, Özçelik U. Dogru D, et al. Among authors: emiralioglu n. Pediatr Pulmonol. 2020 Feb;55(2):541-548. doi: 10.1002/ppul.24561. Epub 2019 Nov 11. Pediatr Pulmonol. 2020. PMID: 31710166
Patients with cystic fibrosis who could not receive the CFTR modulator treatment: What did they lose in 1 year?
Uytun S, Cinel G, Eryılmaz Polat S, Özkan Tabakçı S, Kiper N, Yalçın E, Ademhan Tural D, Özsezen B, Şen V, Selimoğlu Şen H, Ufuk Altıntaş D, Çokuğraş H, Kılınç AA, Başkan AK, Yazan H, Çollak A, Uzuner S, Ünal G, Yılmaz Aİ, Çağlar HT, Damadoğlu E, Irmak İ, Demir E, Kartal Öztürk G, Bingöl A, Başaran E, Sapan N, Canıtez Y, Tana Aslan A, Asfuroğlu P, Harmancı K, Köse M, Hangül M, Özdemir A, Çobanoğlu N, Özcan G, Keskin Ö, Yüksel H, Özdoğan Ş, Topal E, Çaltepe G, Can D, Korkmaz Ekren P, Kılıç M, Emiralioğlu N, Şişmanlar Eyüboğlu T, Pekcan S, Çakır E, Özçelik U, Doğru D. Uytun S, et al. Among authors: emiralioglu n. Pediatr Pulmonol. 2023 Sep;58(9):2505-2512. doi: 10.1002/ppul.26535. Epub 2023 Jun 6. Pediatr Pulmonol. 2023. PMID: 37278544
Geographical barriers to timely diagnosis of cystic fibrosis and anxiety level of parents during newborn screening in Turkey.
Gokdemir Y, Eyuboglu TS, Emiralioglu N, Er B, Sen V, Pekcan S, Ergenekon AP, Hizal MG, Eryilmaz S, Kose M, Hangul M, Cakir E, Cokugras H, Kılınc AA, Sasıhuseyinoglu AS, Altintas DU, Gulen F, Eski A, Bingol A, Ozdemir A, Topal E, Gursoy TR, Girit S, Ay P, Yılmaz O. Gokdemir Y, et al. Among authors: emiralioglu n. Pediatr Pulmonol. 2021 Oct;56(10):3223-3231. doi: 10.1002/ppul.25586. Epub 2021 Jul 29. Pediatr Pulmonol. 2021. PMID: 34273142
International management platform for children's interstitial lung disease (chILD-EU).
Griese M, Seidl E, Hengst M, Reu S, Rock H, Anthony G, Kiper N, Emiralioğlu N, Snijders D, Goldbeck L, Leidl R, Ley-Zaporozhan J, Krüger-Stollfuss I, Kammer B, Wesselak T, Eismann C, Schams A, Neuner D, MacLean M, Nicholson AG, Lauren M, Clement A, Epaud R, de Blic J, Ashworth M, Aurora P, Calder A, Wetzke M, Kappler M, Cunningham S, Schwerk N, Bush A; the other chILD-EU collaborators. Griese M, et al. Among authors: emiralioglu n. Thorax. 2018 Mar;73(3):231-239. doi: 10.1136/thoraxjnl-2017-210519. Epub 2017 Oct 22. Thorax. 2018. PMID: 29056600 Free article. Clinical Trial.
Childhood diffuse parenchymal lung diseases: We need a new classification.
Cinel G, Kiper N, Orhan D, Emiralioğlu N, Yalçın E, Doğru D, Özçelik U, Oğuz B, Haliloğlu M. Cinel G, et al. Among authors: emiralioglu n. Clin Respir J. 2020 Feb;14(2):102-108. doi: 10.1111/crj.13106. Epub 2019 Dec 8. Clin Respir J. 2020. PMID: 31724297
Prospective evaluation of hydroxychloroquine in pediatric interstitial lung diseases: Study protocol for an investigator-initiated, randomized controlled, parallel-group clinical trial.
Griese M, Köhler M, Witt S, Sebah D, Kappler M, Wetzke M, Schwerk N, Emiralioglu N, Kiper N, Kronfeld K, Ruckes C, Rock H, Anthony G, Seidl E. Griese M, et al. Among authors: emiralioglu n. Trials. 2020 Apr 3;21(1):307. doi: 10.1186/s13063-020-4188-4. Trials. 2020. PMID: 32245508 Free PMC article.
136 results